Beneficient BENF Redeemable NCI
Redeemable NCI at other companies
Other financials
Where this comes from
Reported directly by Beneficient in its filing.
Tagged under the XBRL concept us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests.
The official record: Beneficient’s 10-Q, filed February 17, 2026, on SEC EDGAR. View the filing →
Ask your AI about Beneficient's redeemable nci.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Beneficient's redeemable NCI?
- Beneficient (BENF) reported redeemable NCI of $90.53M in Q4 2025.
- How has Beneficient's redeemable NCI changed year-over-year?
- Beneficient's redeemable NCI decreased by 0.0% year-over-year, from $90.53M to $90.53M.
- What is the long-term trend for Beneficient's redeemable NCI?
- Over 3 years (2022 to 2025), Beneficient's redeemable NCI has grown at a -63.8% compound annual growth rate (CAGR), from $1.91B to $90.53M.
- What does redeemable NCI mean?
- Minority interests in subsidiaries that include a put option allowing the minority holder to require the parent to repurchase their stake.